Amaero (3DA) Registration filing summary

Company overview and business model

• Tennessee-based producer of high-purity spherical refractory and titanium alloy powders for additive manufacturing, plus large near-net-shape PM-HIP components for defense, aerospace, space, medical, energy and industrial applications.

• Crucible-free EIGA Premium atomizers target powder purity and consistency; PM-HIP makes dense components with forged-equivalent properties as an alternative to constrained domestic casting and forging capacity.

• Three atomizers commissioned; current planned annual capacity 680 metric tons, with a 720-ton maximum by product mix. A fourth is expected in June 2027, raising planned capacity to 920 tons and maximum capacity to 960 tons.

• Commercial relationships include exclusive or preferred supplier agreements with Velo3D, ADDMAN Group, Titomic and United Performance Metals; July 2026 backlog was $15.3M across 26 customers.

• Redomiciled from Australia to Delaware on June 22, 2026; ASX-listed CDIs continue under 3DA, with each CDI representing 1/40th of a common share.

Financial performance and metrics

• FY2025 revenue $6.305M vs. $1.317M in FY2024; gross loss $5.163M vs. $2.843M; continuing-operations loss $18.548M vs. $13.394M.

• H1 2026 revenue $7.397M vs. $1.219M H1 2025; gross loss narrowed to $3.077M from $3.277M, while continuing-operations loss widened to $13.433M from $8.901M.

• H1 2026 Adjusted EBITDA loss was $8.512M vs. $7.650M H1 2025; net cash used in operating activities was $12.903M vs. $6.985M.

• Backlog rose from $0.4M at Dec. 31, 2024 to $6.9M at Dec. 31, 2025, $10.0M at June 30, 2026 and $15.3M at July 31, 2026.

• At June 30, 2026: cash and cash equivalents $13.6M, net debt carrying value $19.6M, PP&E $45.9M and total assets $88.6M.

Use of proceeds and capital allocation

• Estimated net proceeds of $46.1M at the assumed $7.06/share price, or $53.4M if the underwriters exercise the option in full, after estimated discounts and offering expenses.

• Up to $17.5M is intended for capital equipment over the next 12 months; remaining proceeds for working capital, operating expenses and R&D, with possible acquisitions or investments at management’s discretion.

• Additional planned build-out includes the fourth atomizer, argon recycling, powder-processing and PM-HIP equipment, and facility improvements; remaining investment estimate was $16.5M as of the filing.